vs

Side-by-side financial comparison of Ranpak Holdings Corp. (PACK) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $93.7M, roughly 1.5× Ranpak Holdings Corp.). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 2.3%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 13.7%).

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

PACK vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.5× larger
TOI
$142.0M
$93.7M
PACK
Growing faster (revenue YoY)
TOI
TOI
+39.3% gap
TOI
41.6%
2.3%
PACK
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
13.7%
PACK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACK
PACK
TOI
TOI
Revenue
$93.7M
$142.0M
Net Profit
$-7.5M
Gross Margin
39.0%
Operating Margin
-1.0%
-4.9%
Net Margin
-5.3%
Revenue YoY
2.3%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.11
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACK
PACK
TOI
TOI
Q4 25
$93.7M
$142.0M
Q3 25
$83.6M
$136.6M
Q2 25
$77.8M
$119.8M
Q1 25
$77.6M
$104.4M
Q4 24
$91.6M
$100.3M
Q3 24
$78.6M
$99.9M
Q2 24
$72.8M
$98.6M
Q1 24
$72.5M
$94.7M
Net Profit
PACK
PACK
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-10.4M
$-16.5M
Q2 25
$-7.5M
$-17.0M
Q1 25
$-10.9M
$-19.6M
Q4 24
$-13.2M
Q3 24
$-8.1M
$-16.1M
Q2 24
$5.5M
$-15.5M
Q1 24
$-8.1M
$-19.9M
Gross Margin
PACK
PACK
TOI
TOI
Q4 25
39.0%
Q3 25
41.1%
Q2 25
37.1%
Q1 25
39.8%
Q4 24
45.2%
Q3 24
43.8%
Q2 24
43.5%
Q1 24
44.6%
Operating Margin
PACK
PACK
TOI
TOI
Q4 25
-1.0%
-4.9%
Q3 25
-6.8%
-5.9%
Q2 25
-12.5%
-9.4%
Q1 25
-10.3%
-9.5%
Q4 24
1.5%
-11.9%
Q3 24
-5.3%
-13.9%
Q2 24
-7.1%
-16.6%
Q1 24
-6.6%
-19.0%
Net Margin
PACK
PACK
TOI
TOI
Q4 25
-5.3%
Q3 25
-12.4%
-12.1%
Q2 25
-9.6%
-14.2%
Q1 25
-14.0%
-18.8%
Q4 24
-13.1%
Q3 24
-10.3%
-16.1%
Q2 24
7.6%
-15.7%
Q1 24
-11.2%
-21.0%
EPS (diluted)
PACK
PACK
TOI
TOI
Q4 25
$-0.11
$-0.04
Q3 25
$-0.12
$-0.14
Q2 25
$-0.09
$-0.15
Q1 25
$-0.13
$-0.21
Q4 24
$-0.13
$-0.14
Q3 24
$-0.10
$-0.18
Q2 24
$0.07
$-0.17
Q1 24
$-0.10
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACK
PACK
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$63.0M
Total DebtLower is stronger
$401.9M
Stockholders' EquityBook value
$534.9M
$-15.7M
Total Assets
$1.1B
$164.7M
Debt / EquityLower = less leverage
0.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACK
PACK
TOI
TOI
Q4 25
$63.0M
Q3 25
$49.9M
Q2 25
$49.2M
Q1 25
$65.5M
Q4 24
$76.1M
Q3 24
$69.5M
Q2 24
$65.1M
$9.9M
Q1 24
$55.1M
$29.8M
Total Debt
PACK
PACK
TOI
TOI
Q4 25
$401.9M
Q3 25
$403.1M
Q2 25
$403.1M
Q1 25
$405.2M
Q4 24
$406.4M
Q3 24
$403.2M
Q2 24
$396.1M
Q1 24
$396.7M
Stockholders' Equity
PACK
PACK
TOI
TOI
Q4 25
$534.9M
$-15.7M
Q3 25
$537.8M
$-12.3M
Q2 25
$539.0M
$-9.0M
Q1 25
$544.1M
$5.1M
Q4 24
$548.1M
$3.6M
Q3 24
$564.3M
$15.5M
Q2 24
$566.2M
$29.2M
Q1 24
$560.0M
$41.3M
Total Assets
PACK
PACK
TOI
TOI
Q4 25
$1.1B
$164.7M
Q3 25
$1.1B
$163.6M
Q2 25
$1.1B
$159.8M
Q1 25
$1.1B
$164.0M
Q4 24
$1.1B
$172.7M
Q3 24
$1.1B
$179.2M
Q2 24
$1.1B
$179.6M
Q1 24
$1.1B
$204.5M
Debt / Equity
PACK
PACK
TOI
TOI
Q4 25
0.75×
Q3 25
0.75×
Q2 25
0.75×
Q1 25
0.74×
Q4 24
0.74×
Q3 24
0.71×
Q2 24
0.70×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACK
PACK
TOI
TOI
Operating Cash FlowLast quarter
$19.5M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACK
PACK
TOI
TOI
Q4 25
$19.5M
$3.2M
Q3 25
$8.5M
$-12.6M
Q2 25
$-3.6M
$-10.2M
Q1 25
$-1.3M
$-5.0M
Q4 24
$6.5M
$4.2M
Q3 24
$10.1M
$819.0K
Q2 24
$19.6M
$-15.7M
Q1 24
$5.2M
$-15.9M
Free Cash Flow
PACK
PACK
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$417.0K
Q2 24
$-17.5M
Q1 24
$-16.5M
FCF Margin
PACK
PACK
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Q1 24
-17.4%
Capex Intensity
PACK
PACK
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Q1 24
0.6%
Cash Conversion
PACK
PACK
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons